Fishel et al (n = 108) randomised women with Type 2 diabetes before 21 weeks' gestation to receive insulin detemir or NPH insulin (neutral protamine Hagedorn) in a comparative effectiveness trial.15 This evidence concerns the gene INS and type 2 diabetes mellitus.